JPMorgan Starts Rigel Pharmaceuticals (RIGL) at Overweight
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $1.08 -4.42%
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
JPMorgan initiates coverage on Rigel Pharmaceuticals (NASDAQ: RIGL) with an Overweight. PT $14.00.
For more ratings news on Rigel Pharmaceuticals click here and for the rating history of Rigel Pharmaceuticals click here.
Shares of Rigel Pharmaceuticals closed at $6.97 yesterday.
For more ratings news on Rigel Pharmaceuticals click here and for the rating history of Rigel Pharmaceuticals click here.
Shares of Rigel Pharmaceuticals closed at $6.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Starts Bitfarms Ltd. (BITF) at Outperform
- Monster Beverage (MNST) cut to sell at Truist as its 'no longer see it as a high growth story'
- Victoria's Secret (VSCO) initiated with sell rating at Goldman Sachs on 'less attractive' risk/reward
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
